Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
Aims. To conduct an analysis of modern antihyperglycemic prescription patterns in type 2 diabetes mellitus (T2DM). Materials and methods. Russian DM State registry was studied. Results. We obtained absolute and comparative data on use of insulin analogues, dipeptidyl peptidase-4 (DPP-4) inhibitor...
Main Author: | Yury Ivanovich Suntsov |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2012-03-01
|
Series: | Сахарный диабет |
Subjects: | |
Online Access: | https://www.dia-endojournals.ru/jour/article/view/5971 |
Similar Items
-
Comparison of Glucose Lowering Efficacy of Human GLP-1 Agonist in Taiwan Type 2 Diabetes Patients after Switching from DPP-4 Inhibitor Use or Non-Use
by: Chia-Jen Tsai, et al.
Published: (2022-11-01) -
An update on the role of antihyperglycemic agents in diabetoporosis
by: Nidhi Sharma, et al.
Published: (2023-01-01) -
The Anti-Inflammatory Effect of Novel Antidiabetic Agents
by: Panagiotis Theofilis, et al.
Published: (2022-11-01) -
Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors
by: Mariusz Dąbrowski
Published: (2021-02-01) -
Utility of Hypoglycemic Agents to Treat Asthma with Comorbid Obesity
by: Derek Ge, et al.
Published: (2022-12-01)